Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02760095 · ClinicalTrials.gov registry record
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 46
- Enrollment target
NCT02760095: Completed study, sponsored by University of Colorado, Denver.
NCT02760095 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02760095 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The overall objective is to determine the impact of EED on zinc absorption and homeostasis, and its impact on the absorptive capacity of vitamin A absorption of young children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies.
Primary Outcome
Absorption of zinc from standard 3 mg dose will be measured using zinc isotope tracer methods
Interventions
- DRUG 3 mg zinc sulfate supplement
- DRUG 0.5 mg of 13C10-retinyl-acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-06 |
What the finished NCT02760095 record still lists
NCT02760095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which 3 mg zinc sulfate supplement is the first listed.
NCT02760095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02760095 about?
NCT02760095 is a clinical study titled "Effects of EED on Zn Absorption and Retention in Children From a Standard Dose". The overall objective is to determine the impact of EED on zinc absorption and homeostasis, and its impact on the absorptive capacity of vitamin A absorption of young children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies.
What is the current status of trial NCT02760095?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2015-11. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02760095?
The interventions under investigation include: 3 mg zinc sulfate supplement (DRUG), 0.5 mg of 13C10-retinyl-acetate (DRUG).
Who is sponsoring clinical trial NCT02760095?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia